Invesco Markets III

Notice

RNS Number : 0984D
Invesco Markets III PLC
14 February 2020
 


Invesco Markets III Plc

Central Quay, Riverside IV

Sir John Rogerson's Quay

Dublin 2

Ireland

_____________________________________

Telephone : +353 1 439 8000

www.invesco.com

IMPORTANT: This letter is important and requires your immediate attention.  If you have any questions about the content of this letter, you should seek independent professional financial advice.

 

14 February 2020

 

Invesco Markets III plc (the "Company")

Mandatory Redemption Price

 

Funds

ISINs

NAV Rates

NAV Date

Invesco Dynamic US Markets UCITS ETF

IE00B23D9240

19.49128

12.02.2020

Invesco FTSE RAFI Europe Mid-Small UCITS ETF

IE00B23D8Y98

16.82855

12.02.2020

Invesco S&P 500 VEQTOR UCITS ETF

IE00BX8ZXS68

27.63336

12.02.2020

 

(the "Funds")

 

Dear Shareholder

 

Further to the shareholder notice dated 7 November 2019, the Company confirms that the shares of the Funds were redeemed on 12 February 2020 and the resulting cash proceeds will be paid on or around 19 February 2020 at the rates set in the above table.

 

The Company has requested the cancellation of the listings of the Funds. This was effective as of close of business on 10 February 2020 for the Funds.

 

Investors should consult their own professional adviser as to the specific tax implications of the termination under the laws of the countries of their nationality, residence, domicile or incorporation.

 

If you have any queries arising from this notice, please call +44 (0)20 3370 1113 or contact us at [email protected]

 

Yours faithfully

 

_________________________

Director

For and behalf of

Invesco Markets III Public Limited Company

 

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEXZLFFBLLLBBD